---
figid: PMC6803543__fonc-09-01026-g0003
figtitle: Ras signaling pathway shown as an interacting network
organisms:
- Homo sapiens
pmcid: PMC6803543
filename: fonc-09-01026-g0003.jpg
figlink: /pmc/articles/PMC6803543/figure/F3/
number: F3
caption: Ras signaling pathway shown as an interacting network. This pathway was hyperactivated
  in the patient's tumor tissue. Green arrows indicate activation, red arrows–inhibition.
  Transcript nodes are shown in ovals, interface molecular pathways and cellular effects–in
  rectangles. The color depth of transcript nodes reflects the extent of node activation
  (logarithms of the case-to-normal (CNR) expression rate for each node, in which
  “normal” is a geometric average between expression levels in normal tissue samples).
  Molecular targets of crizotinib and bevacizumab are indicated by black arrows. Visualization
  was implemented using Oncobox software.
papertitle: Transcriptomics-Guided Personalized Prescription of Targeted Therapeutics
  for Metastatic ALK-Positive Lung Cancer Case Following Recurrence on ALK Inhibitors.
reftext: Elena Poddubskaya, et al. Front Oncol. 2019;9:1026.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8359284
figid_alias: PMC6803543__F3
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6803543__F3
ndex: 17adee4e-df25-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6803543__fonc-09-01026-g0003.html
  '@type': Dataset
  description: Ras signaling pathway shown as an interacting network. This pathway
    was hyperactivated in the patient's tumor tissue. Green arrows indicate activation,
    red arrows–inhibition. Transcript nodes are shown in ovals, interface molecular
    pathways and cellular effects–in rectangles. The color depth of transcript nodes
    reflects the extent of node activation (logarithms of the case-to-normal (CNR)
    expression rate for each node, in which “normal” is a geometric average between
    expression levels in normal tissue samples). Molecular targets of crizotinib and
    bevacizumab are indicated by black arrows. Visualization was implemented using
    Oncobox software.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - GDNF
  - GNAL
  - GNPNAT1
  - RALGDS
  - RET
  - TEK
  - GFRA1
  - BCR
  - RN7SL263P
  - LAT
  - ORC3
  - SPNS1
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - CDC42
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - DOK1
  - SHC2
  - SHC3
  - RNASE1
  - PAK1
  - PAK2
  - PAK3
  - PAK4
  - PAK5
  - PAK6
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - RASA2
  - SYK
  - ZAP70
  - CRKL
  - GRB2
  - GPLD1
  - PLD1
  - PLD2
  - PLD3
  - PLD4
  - PLD5
  - PLD6
  - FYN
  - LCK
  - CD74
  - ING1
  - LTB
  - CENPK
  - PRICKLE3
  - PKM
  - XYLT2
  - SOS1
  - SOS2
  - RASGRF1
  - RASGRF2
  - KRAS
  - HRAS
  - NRAS
  - EPHB2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - AFDN
  - RIN1
  - RAB5A
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - MEF2A
  - MYEF2
  - MEF2C
  - MEF2D
  - MEF2B
  - JUN
  - CDK6
  - CDK4
  - VAV1
  - VAV2
  - VAV3
  - CREB1
  - ATF2
  - ATF4
  - CREB3
  - CREB3L4
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - AKT2
  - AKT3
  - RASSF5
  - RAP1A
  - RABGEF1
  - TERF2IP
  - RAP1B
  - MYC
  - SHC1
  - RASA3
  - RAPGEF1
  - Crizotinib
  - Calcium
  - Cancer
  - Lung cancer
  - Noonan syndrome
---
